Skip to content

Clinical trials

Cardiovascular Diseases trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Country / region: Taiwan Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20055
20072
20082
20093
20105
20115
20127
20133
20144
20152
20162
20172
20187
20195
20202
20217
20223
20236
20245
202510
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Recruiting17
Unknown status11
Terminated10
Active, not recruiting9
Not yet recruiting2
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital10
Novartis Pharmaceuticals8
Chang Gung Memorial Hospital6
AstraZeneca4
China Medical University Hospital4
GlaxoSmithKline4
Abbott Medical Devices2
Boehringer Ingelheim2
Buddhist Tzu Chi General Hospital2
Cardurion Pharmaceuticals, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases95
Stroke14
Heart Diseases9
Hypertension9
Atherosclerosis8
Diabetes Mellitus, Type 28
Hyperlipidemias8
Myocardial Infarction8
Renal Insufficiency, Chronic8
Metabolic Syndrome7

Trials

Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.